Skip to main content
Advertisement

PLOS ONE

  • Publish
    • Submissions
      • Getting Started
      • Submission Guidelines
      • Figures
      • Tables
      • Supporting Information
      • LaTeX
      • What We Publish
      • Preprints
      • Revising Your Manuscript
      • Submit Now
      • Calls for Papers
    • Policies
      • Best Practices in Research Reporting
      • Human Subjects Research
      • Animal Research
      • Competing Interests
      • Disclosure of Funding Sources
      • Licenses and Copyright
      • Data Availability
      • Complementary Research
      • Materials, Software and Code Sharing
      • Ethical Publishing Practice
      • Authorship
      • Corrections, Expressions of Concern, and Retractions
    • Manuscript Review and Publication
      • Criteria for Publication
      • Editorial and Peer Review Process
      • Editor Center
      • Resources for Editors
      • Guidelines for Reviewers
      • Accepted Manuscripts
      • Comments

    Submit Your Manuscript

    Discover a faster, simpler path to publishing in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time.

    Learn More Submit Now

  • About
    • Why Publish with PLOS ONE
    • Journal Information
    • Staff Editors
    • Editorial Board
    • Section Editors
    • Advisory Groups
    • Find and Read Articles
    • Publishing Information
    • Publication Fees
    • Press and Media
    • Contact
  • Browse
  • Search
    advanced search
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake

  • Masroor Shariff,

    Affiliation Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane, Australia

    ⨯
  • Maryka Quik,

    Affiliation Centre for Health Sciences, Bioscience Division, SRI International, Menlo Park, California, United States of America

    ⨯
  • Joan Holgate,

    Affiliation Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane, Australia

    ⨯
  • Michael Morgan,

    Affiliation Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane, Australia

    ⨯
  • Omkar L. Patkar,

    Affiliation Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane, Australia

    ⨯
  • Vincent Tam,

    Affiliation School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia

    ⨯
  • Arnauld Belmer,

    Affiliation Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane, Australia

    ⨯
  • Selena E. Bartlett

    * E-mail: selena.bartlett@qut.edu.au

    Affiliation Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Brisbane, Australia

    ⨯

Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake

  • Masroor Shariff, 
  • Maryka Quik, 
  • Joan Holgate, 
  • Michael Morgan, 
  • Omkar L. Patkar, 
  • Vincent Tam, 
  • Arnauld Belmer, 
  • Selena E. Bartlett
PLOS
x
  • Published: March 30, 2016
  • https://doi.org/10.1371/journal.pone.0150270
  • Article
  • Authors
  • Metrics
  • Comments
  • Media Coverage
Download PDF
 
  • Citation
  • XML
Print
  • Print article
  • Reprints
Share
  • RedditReddit
  • FacebookFacebook
  • LinkedInLinkedIn
  • MendeleyMendeley
  • TwitterTwitter
  • EmailEmail
  Check for updates via CrossMark
Advertisement

Subject Areas
?

For more information about PLOS Subject Areas, click here.

We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

  • Nicotinic acetylcholine receptors  

    Is the Subject Area "Nicotinic acetylcholine receptors" applicable to this article?

    Thanks for your feedback.

  • Sucrose  

    Is the Subject Area "Sucrose" applicable to this article?

    Thanks for your feedback.

  • Dopamine  

    Is the Subject Area "Dopamine" applicable to this article?

    Thanks for your feedback.

  • Nicotine addiction  

    Is the Subject Area "Nicotine addiction" applicable to this article?

    Thanks for your feedback.

  • Acetylcholine  

    Is the Subject Area "Acetylcholine" applicable to this article?

    Thanks for your feedback.

  • Limbic system  

    Is the Subject Area "Limbic system" applicable to this article?

    Thanks for your feedback.

  • Nicotine replacement therapy  

    Is the Subject Area "Nicotine replacement therapy" applicable to this article?

    Thanks for your feedback.

  • Nucleus accumbens  

    Is the Subject Area "Nucleus accumbens" applicable to this article?

    Thanks for your feedback.

  • Publications
  • PLOS Biology
  • PLOS Medicine
  • PLOS Computational Biology
  • PLOS Genetics
  • PLOS Pathogens
  • PLOS ONE
  • PLOS Neglected Tropical Diseases
  •  
  • PLOS Climate
  • PLOS Digital Health
  • PLOS Global Public Health
  • PLOS Sustainability and Transformation
  • PLOS Water
  • Home
  • Blogs
  • Collections
  • Give feedback
  • LOCKSS
  • Privacy Policy
  • Terms of Use
  • Advertise
  • Media Inquiries
  • Contact

PLOS PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US